x
Visit our new Mobile Website next time you access NetDania with your mobile device

SONOMA PHARMACEUTICALS INC. - COMMON STOCK

0.1505
08-19:41:59 GMT
+0.0004
+0.2665%
ISIN:N/A

Figures - SONOMA PHARMACEUTICALS INC. - COMMON STOCK

Open
0.1505
Close
0.1501
Year Change
-16.5740
Year % Change
-16.5740%
52 Week High
1.5200
52 Week Low
0.1159
Volume
62601
Inc. Vol
107

News - SONOMA PHARMACEUTICALS INC. - COMMON STOCK

09-06:40 GMT
Elastic Brings AI-Driven Attack Discovery To SIEM
Source: Forbes World, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-06:32 GMT
Airtel Africa Slips To Q4 Loss On Weak Revenues; Plans Up To $100 Mln Share Buyback, Dividend
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-06:32 GMT
Dynavax Technologies (DVAX) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-06:32 GMT
Allbirds (BIRD) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-06:32 GMT
Magnite (MGNI) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-06:25 GMT
India’s Famous Luxe Wellness Retreat Is An Antidote To 21st-Century Life
Source: Forbes World, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-06:10 GMT
The Top Generative AI Tools For Art And Design
Source: Forbes World, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-06:05 GMT
European Shares Seen Slightly Higher Ahead Of BoE Rate Decision
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-06:05 GMT
Teekay Q1 Profit Rises - Quick Facts
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-06:05 GMT
Argenx Posts Wider Than Expected Q1 Loss; Operating Income Climbs
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-06:05 GMT
Teekay Tankers Ltd. Q1 Profit Decreases, but beats estimates
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-06:00 GMT
How To Watch Real ‘Martha’ ‘Baby Reindeer’ Interview With Piers Morgan
Source: Forbes World, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-05:36 GMT
Traeger (COOK) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-05:36 GMT
Perion Network (PERI) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-05:36 GMT
Paycor HCM (PYCR) Q3 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-05:36 GMT
TaskUs (TASK) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-05:26 GMT
Chinese PR boss says sorry for glorifying overwork
Source: BBCBusiness, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-05:19 GMT
‘Aura Battler Dunbine’ Gets A Nice New Bit Of Experimental Animation
Source: Forbes World, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-05:05 GMT
New Dnsys X1 Exoskeleton Changes Workouts And Walks
Source: Forbes World, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:56 GMT
Man confessed to surfer deaths, Mexican court told
Source: BBC US-Canada, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:52 GMT
The ‘Armored Core’ Series Is Getting A Proper Merchandising Push
Source: Forbes World, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:49 GMT
‘Heeramandi The Diamond Bazaar’ Is Netflix’s Most-Viewed Indian Series
Source: Forbes World, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:41 GMT
Instacart (CART) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:41 GMT
Sensex, Nifty Open Lower In Cautious Trade; Auto Stocks Surge
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:41 GMT
MannKind (MNKD) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:30 GMT
CAVA Group (NYSE:CAVA): Investors’ Appetite for the Salad Chain Is Growing
Source: NASDAQ Stocks, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:15 GMT
What To Know About New Minimally Invasive Weight Loss Procedure Gastric Mucosal Ablation
Source: Forbes World, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:15 GMT
TV: A Theater In Every Home? Or A Vast Wasteland?
Source: Forbes World, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:15 GMT
RxSight To Sell About 1.79 Mln Shares At $56.00/shr; Stock Down
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:15 GMT
Asian Markets Mixed Amid Cautious Trades
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:15 GMT
Bumble (BMBL) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-04:03 GMT
‘Jump on the Bandwagon,’ Says Bank of America About These 2 Stock Picks
Source: NASDAQ Stocks, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-03:47 GMT
Exact Sciences (EXAS) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-03:47 GMT
SkyWater Technology (SKYT) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-03:27 GMT
Four Ways To Unexpectedly Pivot Your Brand Into A Better One
Source: Forbes World, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-03:19 GMT
Topgolf Callaway Brands (MODG) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-03:19 GMT
Robinhood Markets (HOOD) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-03:19 GMT
Duolingo (DUOL) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-02:53 GMT
2025 Rolls-Royce Cullinan Series II Unveiled
Source: Forbes World, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
09-02:53 GMT
Commonwealth Bank Of Australia Q3 Cash Net Profit Down 5%
Source: NASDAQ US Markets, Symbol: SONOMA PHARMACEUTICALS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
39008.35
-61.92
-0.16%
5181.60
-6.19
-0.12%
18055.38
-13.8
-0.08%
61669.00
350
0.57%
18532.72
-31.03
-0.17%
38081.98
-309.89
-0.81%
3152.76
24.28
0.78%
8376.69
-9.42
-0.11%
18528.64
173.65
0.95%
7718.74
-75.94
-0.97%
22164.40
-138.1
-0.62%
2314.44
5.63
0.24%
83.80
0.066
0.08%
1.07387
-0.00079
-0.07%
155.789
0.413
0.27%
1.24807
-0.00122
-0.10%
0.65688
-0.00087
-0.13%
1.37359
0.00079
0.06%
167.30000
0.321
0.19%
0.86042
0.00025
0.03%
194.43700
0.328
0.17%
0.90853
0.00066
0.07%
0.97565
-0.00004
0.00%
0.59952
-0.00084
-0.14%
105.60800
0.108
0.10%
Top Gainers
Name
Last
+/-
%
0.24
0.14
136.28%
3.19
1.46
84.39%
0.06
0.02
65.71%
0.62
0.23
58.81%
0.05
0.02
57.05%
10.47
3.73
55.34%
0.20
0.07
51.36%
8.14
2.61
47.20%
0.06
0.02
45.00%
2.14
0.64
42.67%
Top Losers
Name
Last
+/-
%
4.17
-6.95
-62.50%
0.08
-0.10
-56.34%
0.02
-0.01
-40.13%
0.04
-0.03
-37.68%
0.01
0.00
-36.19%
0.00
0.00
-35.71%
0.04
-0.02
-34.72%
0.03
-0.02
-34.49%
0.02
-0.01
-32.92%
0.26
-0.13
-32.60%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy